Header Social Media

Our Research
Patient and Families
- Patient Advocacy Groups
- Resources for Patient and Families
Researchers and Clinicians
- Funding Opportunities
- Resources For Researchers and Clinicians
Early Stage Investigators
- Funding Opportunities
- Fellowship in Mitochondrial Medicine
News and Events
- Latest News
About Us

7426: Harnessing resilience in adults with primary mitochondrial disease: A pilot study investigating the feasibility of the Promoting Resilience in Stress Management (PRISM) and clinical-focused narrative (CFN) interventions

Not Yet Recruiting

The North American Mitochondrial Disease Consortium (NAMDC) is part of the Rare Diseases Clinical Research Network (RDCRN), which is funded by the National Institutes of Health (NIH) and led by the National Center for Advancing Translational Sciences (NCATS) through its Division of Rare Diseases Research Innovation (DRDRI). NAMDC is funded under grant number U54NS078059 as a collaboration between NCATS, the National Institute of Neurological Disorders and Stroke (NINDS), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), and the Office of Dietary Supplements (ODS). This website is hosted by the network’s Data Management and Coordinating Center at Cincinnati Children’s Hospital Medical Center, which is funded by NCATS and NINDS under grant number TR002818. The content of this website is solely the responsibility of the NAMDC administrative coordinating center at Columbia University Irving Medical Center and does not necessarily represent the official views of the NIH.